CME Group Price Target Raised to $340

TD Cowen boosts price target on financial services provider's stock

Apr. 12, 2026 at 6:04am

A cinematic close-up of heavy, polished banking machinery and mechanics in shades of steel grey, bronze, and chrome, conceptually representing the secure, powerful infrastructure of global financial markets.An extreme close-up of the complex inner workings of a major financial exchange highlights the robust infrastructure powering global markets.Chicago Today

CME Group (NASDAQ:CME) had its price target increased from $328.00 to $340.00 by TD Cowen in a research note on Thursday. TD Cowen currently has a buy rating on the stock.

Why it matters

The price target increase indicates TD Cowen's bullish outlook on CME Group's financial performance and growth prospects. As a major global derivatives exchange, CME Group's stock performance is closely watched by investors as a barometer for the broader financial markets.

The details

Several other brokerages have also weighed in on CME Group recently. JPMorgan Chase & Co. raised their target price from $262.00 to $266.00 and gave the stock an 'underweight' rating. The Goldman Sachs Group increased their price target from $266.00 to $275.00 and maintained a 'sell' rating. Argus upgraded CME Group from 'hold' to 'strong-buy', while Raymond James Financial boosted their target from $310.00 to $320.00 and reiterated an 'outperform' rating.

  • The research note with the updated price target was released on Thursday, April 12, 2026.

The players

CME Group

A global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX.

TD Cowen

An investment bank that covers CME Group and has issued a buy rating on the stock with a new price target of $340.

Got photos? Submit your photos here. ›

The takeaway

The price target increase from TD Cowen suggests continued optimism around CME Group's financial performance and growth outlook, even as other banks maintain more cautious ratings on the stock. As a major player in global derivatives markets, CME Group's stock is closely watched as an indicator of broader market trends.